Jing-li Zhuang

The paradoxical prognostic role of 1q21 Gain/Amplification in multiple myeloma: every coin has two sides

P. Liu, Tianhong Xu, Jing Li, 2020, Leukemia & lymphoma.

Histological Impact on Follicular Lymphoma Grade 3 Treated With Frontline RCHOP Regimen

Peng Liu, Lijuan Yuan, Zheng Wei, 2021 .

rhTPO combined with chemotherapy and G-CSF for autologous peripheral blood stem cells in patients with refractory/relapsed non-Hodgkin’s lymphoma

Jiong Hu, Jun Zhu, Chun Wang, 2019, Cancer management and research.

CMAR_A_219242 8371..8377

Jiong Hu, Jun Zhu, Chun Wang, 2019 .

Single-Cell Transcriptomes Combining with Consecutive Genomics Reveal Clonal Evolution and Gene Regulatory Networks in Relapsed and Refractory Multiple Myeloma

Jifeng Jiang, Jing Li, Yifeng Sun, 2022, Frontiers in Cell and Developmental Biology.

A prognostic model incorporating inflammatory cells and cytokines for newly diagnosed multiple myeloma patients

Peng Liu, Tianhong Xu, Lijuan Yuan, 2023, Clinical and experimental medicine.

Real World Data on the Efficacy and Safety of Ixazomib Based Therapy in Multiple Myeloma: An Observational Study from China

Jing Li, Zheng Wei, Peng Liu, 2019, Clinical Lymphoma Myeloma and Leukemia.